SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-082261
Filing Date
2022-12-22
Accepted
2022-12-22 17:28:35
Documents
13
Period of Report
2022-12-21
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea170786-8k_biotech.htm   iXBRL 8-K 43839
  Complete submission text file 0001213900-22-082261.txt   275982

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE biot-20221221.xsd EX-101.SCH 4316
3 XBRL DEFINITION FILE biot-20221221_def.xml EX-101.DEF 27210
4 XBRL LABEL FILE biot-20221221_lab.xml EX-101.LAB 37709
5 XBRL PRESENTATION FILE biot-20221221_pre.xml EX-101.PRE 25830
7 EXTRACTED XBRL INSTANCE DOCUMENT ea170786-8k_biotech_htm.xml XML 6989
Mailing Address 545 WEST 25TH STREET 20TH FLOOR NEW YORK NY 10001
Business Address 545 WEST 25TH STREET 20TH FLOOR NEW YORK NY 10001 8586920539
Biotech Acquisition Co (Filer) CIK: 0001825413 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39935 | Film No.: 221482873
SIC: 6770 Blank Checks